Literature DB >> 25009371

Extracorporeal liver support in severe alcoholic hepatitis.

Albert Parés1, Antoni Mas1.   

Abstract

The severity of alcoholic hepatitis (AH) which may coexist with cirrhosis varies greatly, from asymptomatic forms which are detected in alcoholic patients without any sign of liver disease, except laboratory abnormalities, to severe forms characterised by deep jaundice, ascites, hepatic encephalopathy and low prothrombin index. In hospitalized patients the mortality could be as high as 75%. The elevated number of therapeutic proposals reported for more than forty years reveals the lack of efficacy of a particular modality. Even in the most favorable trials, the survival is already very poor and in some cases related to the development of renal failure or hepatorenal syndrome. There are some motivating reports concerning albumin dialysis as a support treatment in patients with severe AH, either alone or in combination with other pharmacological therapies. The favorable effects of albumin dialysis in patients with severe AH suggest that the procedure used alone or in combination with other therapies may have a role in this clinical condition. This will be particularly relevant to offer an alternative therapy in these patients, thus being a potential bridge to recovery or to be listed for liver transplantation.

Entities:  

Keywords:  Acute alcoholic hepatitis; Alcoholic liver disease; Extracorporeal liver support; Hepatorenal syndrome; Molecular Adsorbents Recirculating System; Treatment of alcoholic hepatitis

Mesh:

Substances:

Year:  2014        PMID: 25009371      PMCID: PMC4081670          DOI: 10.3748/wjg.v20.i25.8011

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

Review 1.  Extracorporeal perfusion for the treatment of acute liver failure.

Authors:  H B Stockmann; C A Hiemstra; R L Marquet; J N IJzermans
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

Review 2.  Advances in bioartificial liver devices.

Authors:  J W Allen; T Hassanein; S N Bhatia
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

3.  Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

Authors:  Philippe Mathurin; Charles L Mendenhall; Robert L Carithers; Marie-Jose Ramond; Willis C Maddrey; Peter Garstide; Bernard Rueff; Sylvie Naveau; Jean-Claude Chaput; Thierry Poynard
Journal:  J Hepatol       Date:  2002-04       Impact factor: 25.083

4.  Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis.

Authors:  Rajiv Jalan; Sambit Sen; Christian Steiner; Dharmesh Kapoor; Akeel Alisa; Roger Williams
Journal:  J Hepatol       Date:  2003-01       Impact factor: 25.083

5.  Liver support by extracorporeal blood purification: a clinical observation.

Authors:  J Stange; S R Mitzner; S Klammt; J Freytag; P Peszynski; J Loock; H Hickstein; G Korten; R Schmidt; J Hentschel; M Schulz; M Löhr; S Liebe; W Schareck; U T Hopt
Journal:  Liver Transpl       Date:  2000-09       Impact factor: 5.799

6.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

7.  Phase I clinical trial with the AMC-bioartificial liver.

Authors:  M P van de Kerkhove; E Di Florio; V Scuderi; A Mancini; A Belli; A Bracco; M Dauri; G Tisone; G Di Nicuolo; P Amoroso; A Spadari; G Lombardi; R Hoekstra; F Calise; R A F M Chamuleau
Journal:  Int J Artif Organs       Date:  2002-10       Impact factor: 1.595

Review 8.  Liver transplantation: current status and novel approaches to liver replacement.

Authors:  E B Keeffe
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

9.  Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage.

Authors:  A Parés; J Caballería; M Bruguera; M Torres; J Rodés
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

10.  Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study.

Authors:  Laurent Spahr; Laura Rubbia-Brandt; Jean-Loius Frossard; Emile Giostra; Anne-Laure Rougemont; Jérôme Pugin; Maria Fischer; Hanspeter Egger; Antoine Hadengue
Journal:  J Hepatol       Date:  2002-10       Impact factor: 25.083

View more
  1 in total

Review 1.  New treatment options for alcoholic hepatitis.

Authors:  Saggere Muralikrishna Shasthry; Shiv Kumar Sarin
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.